Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 119-126, January 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sabadie, N.
Right arrow Articles by Bartsch, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sabadie, N.
Right arrow Articles by Bartsch, H.

Comparison of the Hydroxylation of Benzo(a)Pyrene with the Metabolism of Vinyl Chloride, N-Nitrosomorpholine, and N-Nitroso-N'-Methylpiperazine to Mutagens by Human and Rat Liver Microsomal Fractions1

Nicole Sabadie2, Christian Malaveille, Anne-Marie Camus and Helmut Bartsch3

Unit of Chemical Carcinogenesis, International Agency for Research on Cancer, 69372 Lyon Cédex 2, France

Carcinogen metabolism in vitro was studied in 20 surgical liver specimens from adult male and female human subjects. A 60-fold interindividual variation in aryl hydrocarbon [benzo-(a)pyrene] hydroxylase activity was seen; the capacity to convert vinyl chloride, N-nitroso-N'-methylpiperazine, and N-nitrosomorpholine into electrophiles mutagenic to Salmonella typhimurium varied 9-, 17-, and 35-fold, respectively. The mean enzymic capacity relative to that of liver from untreated rats was 84% for vinyl chloride, 42% for N-nitrosomorpholine, and 380% for N-nitroso-N'-methylpiperazine. When aryl hydrocarbon [benzo(a)pyrene] hydroxylase activity in human liver specimens was plotted against mutagenicity in S. typhimurium mediated by liver microsomes from the same specimens, a positive correlation was obtained in the presence of vinyl chloride (r = 0.55; p < 0.1), N-nitrosomorpholine (r = 0.86; p < 0.01), or N-nitroso-N'-methylpiperazine (r = 0.94; p < 0.01). The results are discussed in relation to the possible development of methods for assessing rates of metabolism of environmental carcinogens in human subjects in vivo using nontoxic drugs that are metabolized by the same enzymes that metabolize carcinogens. Hepatic aryl hydrocarbon [benzo(a)pyrene] hydroxylase activity following treatment of rats with phenobarbitone, pregnenolone-16{alpha}-carbonitrile, dibenamine, aminoacetonitrile, or disulfiram, but not after treatment with 3-methylcholanthrene, showed a positive correlation with the mutagenicity of the respective 9000 x g liver supernatant fraction mediated in the presence of N-nitrosomorpholine, vinyl chloride, or aflatoxin B1. These data lend further support that cytochrome P-450-linked monooxygenases in rat liver convert N-nitrosomorpholine, vinyl chloride, and aflatoxin B1 into mutagenic electrophiles.

1 Partially supported by Contract NO 1-CP-55630 from the National Cancer Institute, NIH, Bethesda, Md. Some of the data were presented at the International Colloquium of CNRS, No. 256, on "Mécanismes d'altération et de réparation du DNA, relations avec la mutagénèse et la cancérogénese chimique", 4–9 July, 1976, Menton, France, and at the Seventh International Congress of Pharmacology, 1978, Part, France (8).

2 Visiting acientist from the Department of Biochemistry (Director: Professor D. Gautheron), University of Lyon, Lyon, France.

3 To whom requests for reprints should be addressed.

Received 7/19/79. Accepted 9/20/79.




This article has been cited by other articles:


Home page
MutagenesisHome page
A. Hakura, H. Shimada, M. Nakajima, H. Sui, S. Kitamoto, S. Suzuki, and T. Satoh
Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds
Mutagenesis, May 1, 2005; 20(3): 217 - 228.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R.G. Klein, P. Schmezer, R. Hermann, P. Waas, B. Spiegelhalder, and H. Bartsch
Strong nasal carcinogenicity and genotoxicity of 1-nitroso-4-methylpiperazine after low dose inhalation in rats
Carcinogenesis, August 1, 1999; 20(8): 1629 - 1632.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.